Proton pump inhibitors may affect responses to atezolizumab in patients with urothelial cancer
PPIs are commonly used medications for acid reflux, heartburn, and ulcers. Recent evidence indicates that…
Browsing: urothelial cancer
Cancer cells make blood vessels drug resistant during chemotherapy
Scientists at Hokkaido University, Japan, and collaborators have identified how inflammatory changes in tumours caused…
Combination biomarker predicts response to immune checkpoint therapy in patients with advanced bladder cancer
In patients with metastatic bladder cancer, a novel combination of biomarkers from baseline tumour tissues…
ASCO 2020: Immunotherapy following chemotherapy offers extended survival to patients with advanced urothelial cancer
Treatment with avelumab combined with best supportive care following chemotherapy significantly extended overall survival compared…
FDA approves mitomycin for low-grade upper tract urothelial cancer
The Food and Drug Administration (FDA) approved mitomycin for adult patients with low-grade upper tract…
Immunotherapy treatment after chemotherapy significantly slows metastatic bladder cancer
Using immunotherapy immediately after chemotherapy treatment in patients with metastatic bladder cancer significantly slowed the…
ASCO 2019: Novel targeted-antibody treatment produced responses in nearly half of patients with advanced urothelial cancer
A single arm, phase II clinical trial of 125 patients showed treatment with enfortumab vedotin…
ASCO 2018: Erdafitinib shows promise in urothelial cancer patients with specific mutations
In an international Phase II trial led by researchers at The University of Texas MD…
Smoking linked with worse urothelial cancer prognosis in patients, especially women
SMOKING significantly increases individuals’ risk of developing serious forms of urothelial carcinoma and a higher…